OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,020.00
-120.00 (-1.68%)
Last updated: Oct 10, 2025, 12:33 PM KST

OPTUS Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
110,16598,53485,935101,603112,144138,482
Upgrade
Market Cap Growth
4.76%14.66%-15.42%-9.40%-19.02%8.15%
Upgrade
Enterprise Value
64,99140,62722,71941,39435,90762,531
Upgrade
Last Close Price
6820.006100.005320.006168.816533.497951.19
Upgrade
PE Ratio
10.969.567.9920.2711.349.61
Upgrade
PS Ratio
1.331.201.191.731.962.28
Upgrade
PB Ratio
0.750.690.640.820.881.17
Upgrade
P/TBV Ratio
0.840.770.640.820.881.17
Upgrade
P/FCF Ratio
--9.43--11.94
Upgrade
P/OCF Ratio
12.0611.076.9149.6815.867.94
Upgrade
EV/Sales Ratio
0.780.500.310.710.631.03
Upgrade
EV/EBITDA Ratio
5.173.251.834.752.793.60
Upgrade
EV/EBIT Ratio
7.834.782.787.893.434.22
Upgrade
EV/FCF Ratio
-4.78-2.49--5.39
Upgrade
Debt / Equity Ratio
0.010.010.020.020.000.00
Upgrade
Debt / EBITDA Ratio
0.100.120.170.300.020.03
Upgrade
Debt / FCF Ratio
--0.23--0.04
Upgrade
Asset Turnover
0.510.520.510.430.430.49
Upgrade
Inventory Turnover
2.472.922.522.533.003.59
Upgrade
Quick Ratio
2.523.096.007.127.1310.08
Upgrade
Current Ratio
3.253.697.028.348.0010.89
Upgrade
Return on Equity (ROE)
6.67%7.41%8.31%3.99%8.04%12.71%
Upgrade
Return on Assets (ROA)
3.20%3.37%3.58%2.38%4.85%7.44%
Upgrade
Return on Capital (ROIC)
3.60%3.78%3.88%2.58%5.31%8.14%
Upgrade
Return on Capital Employed (ROCE)
5.60%5.90%6.00%4.20%8.10%12.20%
Upgrade
Earnings Yield
8.63%10.46%12.52%4.93%8.82%10.40%
Upgrade
FCF Yield
-12.34%-2.95%10.60%-3.89%-3.17%8.38%
Upgrade
Payout Ratio
-14.80%14.09%32.01%16.22%11.33%
Upgrade
Buyback Yield / Dilution
-0.19%-0.48%4.18%1.07%0.62%1.20%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.